**Core Concept**
Nigro's regimen is a chemoradiotherapy protocol used in the treatment of anal cancer, combining radiation therapy with chemotherapy. The regimen aims to preserve the anal sphincter and avoid colostomy. It involves the use of **5-fluorouracil (5-FU)** and **mitomycin C**.

**Why the Correct Answer is Right**
Since the correct answer is not specified, I will provide general information about Nigro's regimen. The regimen typically consists of radiation therapy combined with **5-FU** and **mitomycin C**, which are administered concurrently. **5-FU** is a pyrimidine analogue that inhibits thymidylate synthase, while **mitomycin C** is an alkylating agent that cross-links DNA.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of option A, it's challenging to provide a precise explanation. However, any option that does not involve **5-FU** and **mitomycin C** or incorrectly describes the regimen's components would be incorrect.
**Option B:** Similarly, without specifics, any option that inaccurately represents the drugs used or the timing of their administration in Nigro's regimen would be wrong.
**Option C:** This option would be incorrect if it fails to acknowledge the role of **radiation therapy** in conjunction with chemotherapy.
**Option D:** This option would be wrong if it misrepresents the purpose or the outcome of Nigro's regimen, such as not aiming for sphincter preservation.

**Clinical Pearl / High-Yield Fact**
Nigro's regimen is a significant treatment approach for anal cancer, offering a chance for **sphincter preservation** and avoiding the need for a permanent colostomy in many patients. The combination of **chemotherapy** and **radiation** is key to its effectiveness.

**Correct Answer:**